Research graph
References from Phase II Study of Cisplatin/Gemcitabine Plus Necitumumab for Squamous NSCLC After ICI‐Platinum Therapy (WJOG14120L). Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
10.1056/nejmoa1810865
10.1056/nejmoa1810865 · External reference
10.1056/nejmoa1709937
10.1056/nejmoa1709937 · External reference
10.1016/j.esmoop.2023.100879
10.1016/j.esmoop.2023.100879 · External reference
10.1016/s0140‐6736(14)60845‐x
10.1016/s0140‐6736(14)60845‐x · External reference
10.1016/j.eclinm.2023.102303
10.1016/j.eclinm.2023.102303 · External reference
10.1016/j.ejca.2023.01.025
10.1016/j.ejca.2023.01.025 · External reference
10.21037/tlcr‐21‐197
10.21037/tlcr‐21‐197 · External reference
10.3390/cancers16050935
10.3390/cancers16050935 · External reference
10.1371/journal.pone.0127306
10.1371/journal.pone.0127306 · External reference
10.1093/annonc/mdy275
10.1093/annonc/mdy275 · External reference
10.2147/cmar.s219984
10.2147/cmar.s219984 · External reference
10.1016/j.jtocrr.2023.100593
10.1016/j.jtocrr.2023.100593 · External reference
10.1016/s1470‐2045(15)00021‐2
10.1016/s1470‐2045(15)00021‐2 · External reference
10.1016/j.lungcan.2019.01.005
10.1016/j.lungcan.2019.01.005 · External reference
10.1016/j.lungcan.2016.07.019
10.1016/j.lungcan.2016.07.019 · External reference
10.1053/ctrv.1999.0125
10.1053/ctrv.1999.0125 · External reference
10.2165/00003495‐200059004‐00002
10.2165/00003495‐200059004‐00002 · External reference
10.1200/jco.1992.10.4.513
10.1200/jco.1992.10.4.513 · External reference
10.5732/cjc.013.10120
10.5732/cjc.013.10120 · External reference
10.1200/jco.2008.19.1650
10.1200/jco.2008.19.1650 · External reference
